Diagnostics & Research Stock List
Year-to-Date Return
< 0.0%
—
> 10.0%
10-Year Annualized Return
< 0.0%
—
> 10.0%
Sharpe Ratio
< 0.0
—
> 0.1
Omega ratio
< 0.0
—
> 0.1
Sortino ratio
< 0.0
—
> 0.1
Calmar ratio
< 0.0
—
> 0.1
Ulcer Index
< 0.0%
—
> 10.0%
10Y Volatility
< 0.0%
—
> 10.0%
Maximum Drawdown
< 0.0%
—
> 10.0%
Dividend Yield
< 0.0%
—
> 10.0%
| Symbol | Full name | YTD Ret. | 10Y Ann. Ret. | Div. Yield | 10Y Volatility | Max. Drawdown | Sharpe Ratio | Sortino ratio | Omega ratio | Calmar ratio | Ulcer Index |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2359.HK | WuXi AppTec Co Ltd H | 12.6% | N/A | 1.1% | 52.1% | -68.7% | 0.4 | ||||
| 3347.HK | Hangzhou Tigermed Consulting Co Ltd | -54.5% | N/A | 1.5% | 56.1% | -80.9% | -0.8 | ||||
| A | Agilent Technologies, Inc. | -13.5% | 14.0% | 0.7% | 26.2% | -93.3% | -0.6 | ||||
| ABDX.L | Abingdon Health plc | 44.6% | N/A | 0.0% | 125.4% | -97.0% | 1.1 | ||||
| AGL.L | ANGLE plc | -76.0% | -16.6% | 0.0% | 63.5% | -95.9% | -0.8 | ||||
| AKU.TO | Akumin Inc. | -70.8% | N/A | 0.0% | 106.3% | -96.8% | -0.4 | ||||
| ANIX | Anixa Biosciences, Inc. | -23.1% | -3.7% | 0.0% | 105.8% | -99.8% | -0.5 | ||||
| APDN | Applied DNA Sciences, Inc. | -42.8% | -43.3% | 0.0% | 184.2% | -100.0% | -0.4 | ||||
| AWH | Aspira Women's Health Inc. | -33.9% | -21.2% | 0.0% | 88.3% | -100.0% | -0.3 | ||||
| AXDX | Accelerate Diagnostics, Inc. | -39.2% | -29.1% | 0.0% | 82.0% | -99.1% | -0.5 | ||||
| BDSX | Biodesix, Inc. | -35.2% | N/A | 0.0% | 102.8% | -96.9% | -0.3 | ||||
| BIM.PA | Biomerieux SA | 3.9% | 15.6% | 0.8% | 28.2% | -43.6% | 0.3 | ||||
| BIOC | Biocept, Inc. | -99.7% | N/A | 0.0% | 148.1% | -100.0% | -0.6 | ||||
| BNGO | Bionano Genomics, Inc. | -88.6% | N/A | 0.0% | 224.2% | -99.2% | -1.1 | ||||
| BNR | Burning Rock Biotech Limited | -63.2% | N/A | 0.0% | 81.2% | -97.9% | -0.9 | ||||
| CDNA | CareDx, Inc | -13.4% | N/A | 0.0% | 76.5% | -94.9% | -0.3 | ||||
| CELC | Celcuity Inc. | 6.2% | N/A | 0.0% | 75.0% | -85.6% | 0.8 | ||||
| CEMI | Chembio Diagnostics, Inc. | N/A | N/A | N/A | N/A | N/A | N/A | ||||
| CNTG | Centogene N.V. | 32.3% | N/A | 0.0% | 110.9% | -97.5% | 0.4 | ||||
| CODX | Co-Diagnostics, Inc. | -48.8% | N/A | 0.0% | 141.3% | -96.8% | -0.7 |